CN1382735A - Somatostatin yolk antibody and its preparing process - Google Patents
Somatostatin yolk antibody and its preparing process Download PDFInfo
- Publication number
- CN1382735A CN1382735A CN 01129613 CN01129613A CN1382735A CN 1382735 A CN1382735 A CN 1382735A CN 01129613 CN01129613 CN 01129613 CN 01129613 A CN01129613 A CN 01129613A CN 1382735 A CN1382735 A CN 1382735A
- Authority
- CN
- China
- Prior art keywords
- antibody
- somatostatin
- immunity
- bsa
- yolk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A somatostatin (SS) and a bovine serum albumin (BSA) are used to synthesize the artificial antigen (SS-BSA) used as the immunogen, which is used to immunize the layer SPF to obtain the somatostatin yolk antibody which is able to promote growth of animal. When it is applied to the chicken, the comparison between experimental and reference groups shows its high effect on promoting growth and saving feed.
Description
The present invention relates to a kind of antibody of Somatostatin and preparation method thereof.
Somatostatin (Somatostatin is designated hereinafter simply as SS) is a kind of important hormone that extensively is present in each histoorgan of animal body, and it has multiple biological function, as suppressing tethelin (GH), thyrotropin, the secretion of stomach and intestine pancreas hormone etc.; Suppress the release of neurohypophyseal hormone; Suppress the secretion of stomach and the absorption of adjustment stomach and intestine circulation and motion and nutritive substance etc.
Because SS can suppress the release of tethelin in animal body, therefore, eliminate or lower the restraining effect of SS, can improve tethelin emission levels in vivo, promote animal growth.Both at home and abroad all the someone uses in the SS immunity and technology was carried out in this respect research.
As using SS active immunity ox, sheep, animals such as pig descend the intravital SS level of animal, and the GH level improves, and increases the weight of animals (Spencer G.S.G.et al., 1983, Livestock Prod.Sci., 10:469-473; Huang is taken by force earlier, Yao Liansheng etc., 1991, Jiangsu agricultural sciences, (4): 53-54); Huang is taken by force earlier, Yao Liansheng etc., 1991, Jiangsu agricultural journal, 7 (4): 37-40).The shortcoming of this immunization ways is that the immune response that produces is low, and especially initial 1-2 is in the month after immunity, and gaining effect is not obvious, even body weight descends to some extent, and this has just limited the application of active immunity.
The somebody is with the antiserum(antisera) of SS preparation and monoclonal antibody passive immunization rat after treatment, to improve body weight (Maccicchini M.L., 1986, US Patent.4,599,299 Jul.8).Though passive immunization can overcome the low problem of immune response, but sero-fast source is limited, also might have problems such as anaphylaxis.
There is the human gene engineering method to develop the engineering subunit vaccine that to express SS, is used for immune rat, promote growth.But the main drawback of this method still be immunogenicity relatively poor (Xu Wenzhong, Du Nianxing etc., 1993, Chinese science, 23 (12): 1272-1278)
The objective of the invention is to develop a kind of SS antibody, this antibody promotes the effective of growth of animal, is difficult for taking place allergy, and the preparation of this antibody has abundant, the advantages such as output is high, environmental sound in source.
Because the molecular weight of Somatostatin is very little, itself does not have immunogenicity, belongs to haptens.Need connect by chemical process with big carrier proteins, constitute the new immunogenic artificial antigen of SS that has.The key of somatostatin yolk antibody technology of preparing is the screening of carrier proteins and immune programme for children.Both selections have determined the level of tiring of antibody.
The present invention has synthesized the artificial antigen (SS-BSA) of Somatostatin (Somatostatin SS) with bovine serum albumin (Bovine Serum AlbuminBSA), as immunogen, and this artificial antigen is used for immune SPF laying hen, obtained the somatostatin yolk antibody that can promote growth of animal.One. the preparation of artificial antigen:
1. reaction principle:
The N-ethyl, N '-(3-dimethylamino-propyl) carbodiimide hydrochloride (N-ethyl-N '-(3-dimethylaminopropyl) carbodiimide hydrochloride, abbreviate EDC as) as condensing agent, can make dehydrating condensation between amino and carboxyl and form amido linkage.Under the certain reaction condition, the carboxyl on carrier protein or the hapten molecule reacts with carbodiimide earlier, generates intermediate product, and the amino with another carrier proteins or hapten molecule reacts again, forms conjugate, i.e. artificial antigen.
2. preparation method
Chemistry connects:
According to SS and the ratio of the molecular structure of BSA, both amino and carboxyl and the ratio of molecular weight thereof, calculate in same connection system the input ratio of SS and carrier proteins BSA.SS is dissolved in the PBS buffer reagent, and the dissolving back adds BSA, adds condensing agent EDC again; After reaction finishes, by not connecting the haptens of going up carrier proteins in the dialysis method removal system, small molecules such as linking agent, though (dialysis can not be removed macromole such as BSA, but owing to detect the interference that antigen selects for use other carrier proteinss can avoid the BSA antagonist to detect, so need not the BSA in the reaction system is processed), promptly obtain required artificial antigen-SS-BSA.
3. detection of antigens
Use polyacrylamide gel electrophoresis (SDS-PAGE) method to detect the connection effect of coupled reaction product artificial antigen.Get carrier proteins BSA in contrast, carry out electrophoresis, because SS-BSA is more bigger than BSA molecular weight, the band of show sample moves after slightly than the position of BSA as a result.
Two. the preparation of yolk antibody:
1. animal immune:
(1) immunity is prepared: get above-mentioned coupled reaction product S S-BSA artificial antigen, add the Fu Shi Freund's complete adjuvant, and fully emulsified standby; Or get above-mentioned SS artificial antigen, and add freund 's incomplete adjuvant, fully emulsified standby.
(2) immunity:
Get laying hen number, carry out immunity with the SS-BSA artificial antigen, other establishes the blank group of not carrying out immunity, the conventional raising.
Immune programme for children is:
Every thoracic muscle multi-point injection antigen during initial immunity carries out two exempting from (with just to exempt from injection volume identical) after two weeks, two weeks of being separated by are carried out booster immunization (injection volume doubles), carry out the 4th immunity (injection volume is redoublingd) again after two weeks.
2. yolk liquid preparation
Four exempt from the back began to collect the egg that each experimental group chicken is produced in one week, was prepared into yolk liquid and decided antibody titer to descend pacing.
3. antibody test
SS is equivalent to an antigenic determinant in the SS-BSA artificial antigen, detect antigen SS-CWS except that the SS part with SS-BSA is identical, all the other neither with.This shows if this test gained yolk liquid and SS-CWS generation antigen antibody reaction promptly illustrate contains the antibody that is directed to SS in the yolk liquid, its antibody titer is the antibody titer at SS.
With respect to the SS-BSA immune group: use SS-BSA respectively, SS-CWS, BSA, CWS (chicken whole serum chicken whole serum is called for short CWS), EDC is as detecting antigen.The results are shown in Table 1:
The different Detection of antigen results of table 1
Yolk liquid and SS-BSA and SS-CWS react the result that all is positive, and SS-BSA and SS-CWS same antigen composition are SS, and this explanation is the specific antibody structure that has SS in the yolk liquid.
Owing to do not remove BSA during the purifying artificial antigen, so contain the antibody of BSA in the yolk liquid.
4. antibody titer detects
Carry out the detection of antibody titer with agar diffusion method.
Method: use ordinary method to prepare agar gel, (centrifugal 3 minutes cells of dehematizing of 10000rpm are provided by laboratory animal room of China Veterinery Drug Inspection Office behind the aseptic SPF of the taking chicken of the CWS Chicken Whole Serum whole blood to use the chicken whole serum.0.2 μ m filter membrane degerming and impurity) as carrier proteins, make detection antigen SS-CWS with the aforementioned method identical with BSA with connecting SS.With yolk antibody equivalent gradient dilution and SS-CWS reaction, the antibody greatest dilution that responds is antibody titer.It is 1: 32 that present method detects tiring of somatostatin yolk antibody.
Test of three .SS yolk antibody promotes growths and result:
Use SS-BSA yolk antibody immunity chicken, 7 age in days first immunisation, every chicken neck subcutaneous injection 1ml, immunity in per 10 days later on once, dose is identical, and immunity is 6 times altogether, as a result after twice immunity, the mean body weight of test group is that the utmost point is higher than control group significantly, and the mean body weight of test group is higher by 14% than control group during off-test; In addition the feedstuff-meat ratio of test group also the utmost point be significantly higher than control group, and keep significant difference to off-test.
This explanation SS yolk antibody has tangible growth promoting function.
The preparation materials and methods of embodiment 1 Somatostatin and bovine serum albumin artificial antigen (SS-BSA):
1. Somatostatin: Somatostatin-14 (SS), its aminoacid sequence is:
Third-Gan-half Guang-Lai-asparagus fern-phenylpropyl alcohol-phenylpropyl alcohol-Se-Lai-Su-phenylpropyl alcohol-Su-phenylpropyl alcohol-Su---Si-half Guang
Molecular weight: 1637.9 molecular formula: C
76H
104N
18O
19S
2Purity: 〉=98% available from the U.S. biotechnology of crystalline substance company limited.
2. bovine serum albumin component V (BSA Bovine Serum Albumin Fraction V), import packing, molecular weight: 〉=60000
Available from the north with positive biological company limited.
3.N-ethyl, N '-(3-dimethylamino-propyl) carbodiimide hydrochloride (EDC N-Ethyl-N '-(3-dimethylaminopropyl) carbodiimide hydrochloride).Molecular formula: [H
5C
2-N=C=N-CH
2CH
2CH
2-NH
+(CH
3)
2] Cl
-
Available from the magnificent biological company limited in Beijing.
4. damping fluid PBS:
In 800ml distilled water, dissolve 8gNaCl, 0.2g KCl, 1.44gNaHPO
4With 0.24g KH
2PO
4, regulate pH value to 7.2 with HCl, add water and be settled to 1L, 15Ibf/in
2Autoclaving 20 minutes, room temperature preservation.
5. chemistry connects
SS and BSA were in 1: 10 (M: ratio input M), promptly get 1.5mg and be dissolved in (PH7.2) among the 5ml PBS, after dissolving fully, add 15mg bovine serum albumin component five (BSA Fraction V), the solution limit that slowly vibrates adds 3mg EDC, slowly stirs, behind the room temperature reaction 2 hours, slowly add 1mg EDC more while stirring, 4 ℃ are slowly stirred down, reacted 24 hours; After reaction finishes, in volume PBS (PH7.2), dialysed 48 hours down for 4 ℃, connect the haptens of going up carrier proteins, small molecules such as linking agent in the removal system.
Packing 1ml/ part (every part contains SS 0.3mg) ,-40 ℃ of preservations.
6. Detection of antigen
The preparation polyacrylamide gel is got the above-mentioned chemical coupled reaction product of 2 μ l and is detected, and 2 μ l carrier proteins BSA carry out electrophoresis in contrast, because SS-BSA is more bigger than BSA molecular weight, the band of show sample moves after slightly than the position of BSA as a result.
Embodiment 2 animal immunes
(1) immunity is prepared: get 5ml Fu Shi Freund's complete adjuvant under the normal temperature aseptic condition in small beaker, the limit dropwise is added to the immunogen SS-BSA of embodiment 1 preparation of equivalent with small size bar magnet stirring limit; Being stirred well to mixture is milky emulsion.4 ℃ of preservations are standby;
Use the immunogen of freund 's incomplete adjuvant fully with legal system.
(2) immunity:
SPF chicken: get 6 of laying hens of Bai Laihang kind SPF210 age in days (consistent) (available from China Veterinary Drugs Supervisory Inst.), adopt shield retaining to raise with following word; Randomly draw 2 groups in contrast, all the other 4 as immune group, immune SS-BSA artificial antigen, and control group is conventional raises.
Does every chicken (comprise control group to preceding 5 days blood sampling backs of initial immunity?) chest muscle multi-point injection 0.5ml DPT vaccine, every thoracic muscle multi-point injection 0.5ml antigen (is equivalent to every chicken immune SS75 μ g during initial immunity,), carry out two after two weeks and exempt from (identical injection volume), be separated by and carry out booster immunization (injection volume doubles) two weeks, after two weeks, carry out the 4th immunity (injection volume is redoublingd) again.Four exempt from the back began to collect egg in one week, and every egg is indicated group and date, collects egg that immune group is produced after one month and is prepared into yolk liquid.
Just exempt to use the Fu Shi Freund's complete adjuvant, freund 's incomplete adjuvant is used in other immunity several times.
The extraction of embodiment 3 antibody and detection (agar diffusion method):
(1) preparation of agar plate:
100ml 8%NaCl solution adds 1.2 gram agar powders (analytical pure, import packing), and heating and melting adds 0.2ml phenol mixing, pours glass dish into, makes the thick agar plate of 2-3mm, and after room temperature was solidified, 4 ℃ of inversions were preserved stand-by.(2) extraction of the preservation of yolk liquid and yolk antibody: isolate yolk under the aseptic condition, each yolk adds 20ml PBS, and 0.02% Thiomersalate seals 4 ℃ of preservations after the at a high speed even matter.
(2) extraction of yolk antibody (chloroform salting-out process):
Get 100ml yolk liquid and add 100ml PBS damping fluid, the using-system crusher adds 400ml (2 times of volumes) chloroform after carrying out the even matter of high speed again, at a high speed even once more matter; With handled thing with whizzer centrifugal 15 minutes with the speed of 4000rpm; Get supernatant liquor and be the gained yolk antibody.After agar diffusion method is measured antibody titer (1: 32), freezing-10 ℃ of preservations.
(3) dilution of antibody:
With two times of serial dilution serial dilution antibody, get 2 *, 4 *, 8 *, 16 *, 32 *, 64 * and highly diluted multiple more.
(4) agar diffusion reaction:
Before the use, agar plate is broken into seven apertures in the human head blossom type hole, spirit lamp heating back cover with punch tool.During test sample, every hole adds 20 μ l samples, is inverted 37 ℃ of airtight wet boxes of plate 24 hours to 72 hours, produces until precipitation line.
When survey is tired, add antigen at medium pore, periphery holes adds the antibody of different extension rates in certain sequence respectively, and diluent adopts PBS, and extension rate is 2 *, 4 *, 8 *, 16 *, 32 *, 64 *.
Be inverted plate, 37 ℃ of hatching precipitation lines produce, and observe antibody titer, if greatest dilution still has precipitation line, and based on it, serial dilution, reaction repeated is until measuring final antibody dilution multiple, record.
(5) yolk antibody is tired: (centrifugal 3 minutes cells of dehematizing of 10000rpm are provided by laboratory animal room of China Veterinery Drug Inspection Office behind the aseptic SPF of the taking chicken of the CWS Chicken Whole Serum whole blood to use the chicken whole serum.0.2 μ m filter membrane degerming and impurity) as carrier proteins; Get 3mg and be dissolved in (PH7.2) among the 5ml PBS, to dissolving fully, add 5ml chicken whole serum (CWS), the solution limit that slowly vibrates adds 6mg EDC, slowly stirs room temperature reaction 2 hours; Slowly add 1.5mg EDC while stirring, 4 ℃ were reacted 24 hours;
Packing 1ml/ part (every part contains SS 0.3mg) ,-40 ℃ of preservations.
Get yolk antibody, use SS-BSA, SS-CWS is as detecting antigen, and fine jade expansion method detects antibody response, and the result is as follows:
Table 3 yolk antibody is tired
Test of embodiment 4 SS yolk antibody promotes growths and result: (one) test materials and experimental design:
Select 90 of this institute chicken house fine breed of chicken with thick brownish feathers (1 age in days), male and female half and half is raised a week in advance, to 7 ages in days.Weigh chicken body weight close (59 grams ± 5.13 grams) before feeding early morning on an empty stomach.Be divided into 60 of test group at random, 30 of control groups, every group of male and female half and half.Feed adopts basal diet, and trophic level meets national feeding standard, and two groups of feeding and management conditions are identical.
From 7 ages in days, per 7 days (week) every group of early morning, the empty stomach weighing write down the body weight change of every chicken, amounted to for nine weeks, observed its speed of growth and gaining effect.Write down feed consumption rate every group of every day, feed consumption rate/only=establish material amount-surplus material amount/same day chicken number.From 7 ages in days, per 10 days neck subcutaneous injection 1ml of test group, immunity is 6 times altogether, from 17 ages in days, per 10 days (before the immunity), test group is randomly drawed 10 chickens, and control group is randomly drawed 5 chickens, butchers the record body weight, carcass weight and chest muscle and leg flesh are heavy, observe its carcass weight, chest muscle is heavy, and leg flesh heavily reaches dressing percentage etc. and butchers index.
(2) test-results
1. gaining effect
The initial mean body weight of test group is 59.42g, and control group is 59.00g.Initial immunity is spared the body weight indifferences for two groups in 2 weeks.From the 3rd thoughtful (two exempted from back 4 days) six weeks (4 exempted from back 2 days), the test group body weight is significantly higher than control group.To nine weeks, the test group mean body weight still is higher than control group after seven weeks.See Table 4
The gaining effect (gram) of table 4 SS Yolk antibody immunity chicken is weighed time test group average weight control group average weight weight ratio (age in animal used as test week) test group/control group 59.49 ± 5.13 59 ± 5.8 1.008 2 ages 106.42 in week ± 13.72 110.55 ± 17.35 0.96 three in one age in week (starting weight) all ages 175.6 ± 74.4*147.42 age 251.53 ± 38.16 around ± 42.92 1.19
*223.74 ± 48.09 1.12 five ages 381.15 ± 52.19 in week
*339.74 ± 80 1.12 six ages 512 in week ± 73.51 455.43 ± 92.14 1.12 seven ages 641.75 in week ± 80 590.11 ± 124.73 1.08 8 ages 779.5 in week ± 101.09 723.44 ± 162.26 1.08 9 age 929.8 in week ± 156.05 803.25 ± 301.93 1.16
Weigh 997.5 ± 171.19 876.75 ± 308.45 1.14**:P<0.01*:P<0.05 eventually
2. butcher index analysis
Between test group and the control group, when butchering for the first time (17 ages in days, head were exempted from 10 days), everyly butcher index there were significant differences.The results are shown in Table 5
3. feed intake
To five weeks (two exempt from exempt to four between), test group Zhou Pingjun feed consumption rate significantly is lower than control group, after this continues to be lower than control group (table 6) around on-test.
(3) interpretation of result:
From analysis of experimental data, the two mean body weight utmost points of exempting from back (three ages in week age to five in week) experimental group chicken are higher than control group significantly, and keep three weeks of significant difference, though difference is not obvious subsequently, but be kept above the control group mean body weight, with the reform T-check of two groups of average body, difference is extremely remarkable always.
In one to three week of on-test, two groups of feed consumption situations do not have significant difference, and (five week age) rise all around, and the feed consumption rate of test group significantly is lower than control group, and continues to off-test.
Think, in first three week of test, because owing to only carried out twice immunity, SS antibody has just begun and the intravital SS neutralization of chicken, causes that the SS level descends, because SS is the braingut petide hormone, grow by the approach influence that suppresses to digest and assimilate, test group chicken body weight significantly rises and feed consumption rate does not change, and may improve the absorption of digestive tube to nutritive substance for after SS is neutralized a part in the body.Hormonal readinesses such as GH rise not obvious, so weightening finish is not obvious.
Play (three exempt from the back) around on-test, SS further is neutralized in the body, and the secretion of hormones such as GH increases, so the test group body weight continues to keep high level to increase, compares with control group simultaneously, and the gap of feed consumption rate is drawn back significantly.
In the test, two groups of every index no significant differences except that for the first time of butchering are butchered chicken 17 ages in days (head exempted from back 10 days) for the first time, and there were significant differences for two groups of mean body weights at this moment, illustrates that SS antibody has begun to work, conforms to the weightening finish curve.Respectively butchering index does not have significant difference, conforms to former document.Think that with regard to above data analysis SS antibody mediated immunity chicken can grow than obvious facilitation to chicken.
Table 5 different days is butchered back each several part situation
Body weight (gram) | Carcass weight (gram) | Chest muscle heavy (gram) | Leg flesh heavy (gram) | Dressing percentage (carcass weight/body weight) | ||||||
Test group | Control group | Test group | Control group | Test group | Control group | Test group | Control group | Test group | Control group | |
17 ages in days (head exempted from 10 days) | ??126.2 *± ??16.36 | ??102.6 ??±7.37 | ????121.27 *????±18.42 | ??98.44 ??±9.94 | ??9.15 *??±2.67 | ??5.064 ??±1.41 | ????11.72 *????±3.31 | ????7.73 ????±1.62 | ????0.96 | ????0.91 |
27 ages in days (two exempted from 10 days) | ??242.7 ??±29.31 | ??212.8 ??±30.04 | ????216.6 ????±26.55 | ??190 ??±30.5 | ??16.19 ??±3.54 | ??15.88 ??±3.78 | ????23.33 ????±4.28 | ????21.04 ????±4.72 | ????0.89 | ????0.89 |
37 ages in days (three exempted from 10 days) | ??377.8 ??±61.50 | ??364± ??103.61 | ????337.9 ????±54.74 | ??325.48 ??±9.37 | ??29.63 ??±7.85 | ??29.96 ??±10.56 | ????38.17 ????±6.71 | ????37.82± ????13.93 | ????0.89 | ????0.89 |
47 ages in days (four exempted from 10 days) | ??610.1± ??110.77 | ??513.4 ??±120.38 | ????541± ????105.115 | ??465.2 ??±107.56 | ??52± ??13.69 | ??42.82± ??12.36 | ????69.17 ????±15.32 | ????53.64± ????17.87 | ????0.87 | ????0.91 |
57 ages in days (five exempted from 10 days) | ??770.9 ??±63.82 | ??755.8 ??±76.7 | ????689.2± ????58.98 | ??675.6± ??78.38 | ??68.81± ??3.49 | ??70.88± ??7.8 | ????92.34 ????±9.61 | ????91.82± ????12.28 | ????0.89 | ????0.89 |
67 ages in days (six exempted from 10 days) | ??997.5± ??171.87 | ??876.75 ??±308.45 | ????885.8± ????142.83 | ??784.5± ??266.73 | ??94.31± ??16.28 | ??78.975± ??30.76 | ????121.52 ????±27.38 | ????103.58± ????40.8 | ????0.89 | ????0.89 |
The feed consumption situation of table 6 chicken (gram/week. only)
One Zhou Qizhou eight weeks, nine weeks test Saturday Friday Thursday Wednesday Tuesday 15.07 ± 23.64 ± 38.74 ± 49.38
*64.46
*77.01 ± 76.82 101.29 102 ± group 2.49 4.5 5.11 ± 6.81 ± 8.65 10.59 ± 5.9 ± 10 7.35 contrasts 15.04 ± 24.1 ± 40.68 ± 53.83 ± 70.54 ± 82.2 ± 76.88 98.34 110 ± group 2.39 4.44 8.03 7.97 7.55 5.46 ± 3.75 ± 9.61 12.08
Claims (4)
1. artificial antigen, it is characterized in that this antigen be Somatostatin and bovine serum albumin at the N-ethyl, under the effect of N '-(3-dimethylamino-propyl) carbodiimide hydrochloride, condensation forms.
2. a Somatostatin antibody is characterized in that this antibody is that the described artificial antigen of claim 1 is used for immune SPF laying hen, and collect described by the egg that chicken produced of immunity, the somatostatin yolk antibody that from this egg yolk, extracts.
3. the preparation method of the described Somatostatin antibody of claim 2, it is characterized in that the described artificial antigen of claim 1 is used for immune SPF laying hen, and collect described by the egg that chicken produced of immunity, the somatostatin yolk antibody that from this egg yolk, extracts.
4. the preparation method of the described Somatostatin antibody of claim 3 is characterized in that the immune programme for children of described immune SPF laying hen is:
Every thoracic muscle multi-point injection antigen during initial immunity carries out two and exempts from after two weeks, two weeks of being separated by are carried out booster immunization, carries out the 4th immunity again after two weeks.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01129613 CN1218962C (en) | 2001-06-22 | 2001-06-22 | Somatostatin yolk antibody and its preparing process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01129613 CN1218962C (en) | 2001-06-22 | 2001-06-22 | Somatostatin yolk antibody and its preparing process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1382735A true CN1382735A (en) | 2002-12-04 |
CN1218962C CN1218962C (en) | 2005-09-14 |
Family
ID=4669310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01129613 Expired - Fee Related CN1218962C (en) | 2001-06-22 | 2001-06-22 | Somatostatin yolk antibody and its preparing process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1218962C (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1293097C (en) * | 2004-04-15 | 2007-01-03 | 中国农业大学 | Glycyrrhizic acid anti-body and its preparing method and use |
CN101044884B (en) * | 2007-04-26 | 2010-05-19 | 上海交通大学 | Method for prepairng feed additives containing yolk anti body |
CN101759800B (en) * | 2009-12-22 | 2012-07-25 | 湖南大学 | Preparation of dirhamnolipid artificial antigen and antibody, enzyme-linked immunity test paper, preparation and detection method thereof |
CN101455235B (en) * | 2009-01-07 | 2012-12-26 | 大连理工大学 | Special yolk antibody preparation for fruit fresh-keeping, preparation method and use thereof |
CN102914647A (en) * | 2012-05-29 | 2013-02-06 | 安徽农业大学 | Method for detecting duck flavivirus antibody by using agar diffusion method |
CN106957363A (en) * | 2017-03-29 | 2017-07-18 | 广东工业大学 | A kind of peptide Yolk antibody of growth hormone release inhibiting hormone 14 and preparation method thereof |
CN107014991A (en) * | 2017-03-29 | 2017-08-04 | 广东工业大学 | A kind of peptide polyclonal antibody of growth hormone release inhibiting hormone 28 and preparation method thereof |
-
2001
- 2001-06-22 CN CN 01129613 patent/CN1218962C/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1293097C (en) * | 2004-04-15 | 2007-01-03 | 中国农业大学 | Glycyrrhizic acid anti-body and its preparing method and use |
CN101044884B (en) * | 2007-04-26 | 2010-05-19 | 上海交通大学 | Method for prepairng feed additives containing yolk anti body |
CN101455235B (en) * | 2009-01-07 | 2012-12-26 | 大连理工大学 | Special yolk antibody preparation for fruit fresh-keeping, preparation method and use thereof |
CN101759800B (en) * | 2009-12-22 | 2012-07-25 | 湖南大学 | Preparation of dirhamnolipid artificial antigen and antibody, enzyme-linked immunity test paper, preparation and detection method thereof |
CN102914647A (en) * | 2012-05-29 | 2013-02-06 | 安徽农业大学 | Method for detecting duck flavivirus antibody by using agar diffusion method |
CN106957363A (en) * | 2017-03-29 | 2017-07-18 | 广东工业大学 | A kind of peptide Yolk antibody of growth hormone release inhibiting hormone 14 and preparation method thereof |
CN107014991A (en) * | 2017-03-29 | 2017-08-04 | 广东工业大学 | A kind of peptide polyclonal antibody of growth hormone release inhibiting hormone 28 and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1218962C (en) | 2005-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Martin et al. | Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis | |
CN1062605C (en) | Escherichia coli vaccine | |
CN1163270C (en) | Modified meningococcal polysacharide conjugate vaccines | |
AU2013280718B2 (en) | Attenuated Streptococcus suis vaccines and methods of making and use thereof | |
CN1020857C (en) | Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses | |
CN1099894C (en) | Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment | |
CN112870341A (en) | Goat infectious pleuropneumonia subunit vaccine and preparation method and application thereof | |
CN1218962C (en) | Somatostatin yolk antibody and its preparing process | |
CN1059471A (en) | Heamophilus paragallinarum vaccine | |
CN101981052B (en) | Compositions, methods and kits | |
CN113082202A (en) | Composite water-soluble animal vaccine adjuvant, vaccine and preparation method of vaccine | |
CN109207502A (en) | Porcine mycoplasmal pneumonia and porcine circovirus 2 type recombinant protein and prepare bigeminy vaccine | |
CN1264857C (en) | Recombinant fusion protein (vaccine) compsn. contg. same and method for prodn. thereof | |
CN1106858C (en) | Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases | |
CN111973738A (en) | Nucleic acid and recombinant protein co-immune vaccine based on hog cholera virus gene, preparation method and application | |
CN1749274A (en) | Separating and purifying method for new recombinant human interferon alpha2b | |
CN109608541B (en) | Yolk antibody for resisting swine enterotoxigenic escherichia coli and preparation method thereof | |
CN1292794C (en) | Preparation of immuno-stimulation composition for hemolycin in monad | |
CN102321180B (en) | Polypeptide fragment composition and application in preparation of porcine reproductive and respiratory syndrome vaccine thereof | |
CN101050448A (en) | Oral recombined DNA vaccine for accelerating growth of animal, and application | |
CN1209163C (en) | Meningococcal vaccine and its preparing method | |
TW200418874A (en) | Passive vaccine for the prevention of campylobacter colonization, and its preparation method | |
DEGUCHI et al. | Influence of inoculation site of combined oil-adjuvanted vaccine on the antibody response in chickens | |
CN1305527C (en) | Vaccine for treating hepatitis B, and its prepn. method | |
CN1931363A (en) | Toxoplasma metabolic secretion antigen vaccine and its prepn process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050914 Termination date: 20140622 |
|
EXPY | Termination of patent right or utility model |